MWNA
PFE icon

Marshall Wace North America’s Pfizer PFE Stock Holding History

Marshall Wace North America’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$204M Buy
4,738,171
+4,224,072
+822% +$187M 0.87% 19
2021
Q2 		$20.1M Sell
514,099
-1,034,237
-67% -$40.2M 0.08% 255
2021
Q1 		$56.1M Buy
1,548,336
+1,528,472
+7,695% +$54.3M 0.23% 99
2020
Q4 		$731K Sell
19,864
-208,811
-91% -$7.66M ﹤0.01% 1015
2020
Q3 		$7.96M Buy
228,675
+204,457
+844% +$7.17M 0.05% 315
2020
Q2 		$751K Sell
24,218
-4,878,680
-100% -$166M 0.01% 841
2020
Q1 		$152M Sell
4,902,898
-3,625,164
-43% -$124M 1.15% 13
2019
Q4 		$317M Buy
8,528,062
+3,715,433
+77% +$132M 1.53% 5
2019
Q3 		$164M Buy
4,812,629
+4,692,850
+3,918% +$171M 0.93% 23
2019
Q2 		$4.92M Sell
119,779
-7,713,522
-98% -$306M 0.03% 367
2019
Q1 		$316M Buy
7,833,301
+2,710,494
+53% +$109M 2.23% 3
2018
Q4 		$212M Sell
5,122,807
-532,816
-9% -$22.1M 2.05% 6
2018
Q3 		$236M Buy
5,655,623
+1,105,422
+24% +$42.6M 1.62% 9
2018
Q2 		$157M Sell
4,550,201
-234,843
-5% -$8.03M 0.88% 16
2018
Q1 		$161M Sell
4,785,044
-2,060,771
-30% -$70.8M 0.81% 16
2017
Q4 		$235M Buy
6,845,815
+1,656,002
+32% +$56.5M 1.3% 6
2017
Q3 		$177M Buy
5,189,813
+731,870
+16% +$23.5M 1.12% 7
2017
Q2 		$144M Buy
4,457,943
+2,621,997
+143% +$82.7M 1.05% 6
2017
Q1 		$59.2M Buy
+1,835,946
New +$57.9M 0.47% 51
2013
Q4 		$31.7M Buy
1,089,643
+254,183
+30% +$7.4M 0.67% 38
2013
Q3 		$22.8M Buy
835,460
+162,870
+24% +$4.43M 0.7% 27
2013
Q2 		$17.9M Buy
+672,590
New +$18.6M 1.41% 1

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Marshall Wace North America's PFE Position: Q3 2021 in Review

Marshall Wace North America increased its Pfizer (PFE) stake by 822% in Q3 2021, buying an estimated $187M and bringing the position to 4,738,171 shares worth $204M. The position accounts for 0.87% of the portfolio, ranked #19.

Marshall Wace North America first reported a position in PFE in Q2 2013 and has held it in 22 quarters since. The position peaked at $317M in Q4 2019. 2,804 funds tracked by Wall St. Rank hold PFE as of Q3 2021.

  • Marshall Wace North America held 4,738,171 shares of Pfizer worth $204M as of Q3 2021.
  • Marshall Wace North America bought 4,224,072 Pfizer shares in Q3 2021, an estimated $187M.
  • Pfizer made up 0.87% of Marshall Wace North America's portfolio in Q3 2021, its #19 holding.
  • Marshall Wace North America first reported a position in Pfizer in Q2 2013 and has held it in 22 quarters since.
  • Marshall Wace North America's Pfizer position peaked at $317M in Q4 2019.
  • 2,804 funds tracked by Wall St. Rank held Pfizer as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.